Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

IPH

Innate Pharma (IPH)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:IPH
DataOraFonteTitoloSimboloCompagnia
19/12/202313:38MF Dow Jones (Italiano)Le azioni di Innate Pharma salgono dopo l'esercizio dell'opzione dilicenza da parte di SanofiEU:IPHInnate Pharma
19/12/202313:28Dow Jones NewsInnate Pharma Shares Rise after Sanofi Exercises Licensing OptionEU:IPHInnate Pharma
19/12/202308:39Dow Jones NewsSanofi exerce une option de licence en oncologie auprès d'Innate PharmaEU:IPHInnate Pharma
05/10/202314:14Dow Jones NewsInnate Pharma Shares Fall Premarket on FDA Partial Study HoldEU:IPHInnate Pharma
08/06/202316:53Dow Jones NewsInnate Pharma Shares Rise 8% After Cancer Treatment Gets Fast Track DesignationEU:IPHInnate Pharma
19/12/202208:25Dow Jones NewsSanofi et Innate Pharma étendent leur collaboration en oncologie avec les cellules NKEU:IPHInnate Pharma
01/08/202212:30Dow Jones NewsInnate Pharma Shares Slide After Failure of Monalizumab in Head, Neck CancerEU:IPHInnate Pharma
23/09/202107:00GlobeNewswire Inc.Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er septembre 2021EU:IPHInnate Pharma
23/09/202107:00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021EU:IPHInnate Pharma
17/09/202113:45GlobeNewswire Inc.Monalizumab Data From COAST Trial Presented at ESMO Congress 2021EU:IPHInnate Pharma
17/09/202113:45GlobeNewswire Inc.Présentation de Données Issues de l'Essai COAST Comprenant Monalizumab au Congrès de l'ESMO 2021EU:IPHInnate Pharma
17/09/202113:45GlobeNewswire Inc.Monalizumab Data from COAST Trial Presented at ESMO Congress 2021EU:IPHInnate Pharma
15/09/202107:00GlobeNewswire Inc.Innate Pharma reports first half 2021 financial results and business updateEU:IPHInnate Pharma
15/09/202107:00GlobeNewswire Inc.Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2021EU:IPHInnate Pharma
15/09/202107:00GlobeNewswire Inc.Rapport Financier Semestriel 30 juin 2021EU:IPHInnate Pharma
15/09/202107:00GlobeNewswire Inc.Innate Pharma Reports First Half 2021 Financial Results and Business UpdateEU:IPHInnate Pharma
07/09/202107:00GlobeNewswire Inc.Innate Pharma Organise une Conférence Téléphonique et un Webcast pour ses Résultats Financiers au Premier Semestre 2021EU:IPHInnate Pharma
07/09/202107:00GlobeNewswire Inc.Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business UpdateEU:IPHInnate Pharma
02/09/202108:00GlobeNewswire Inc.Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual CongressEU:IPHInnate Pharma
02/09/202108:00GlobeNewswire Inc.Des données sur monalizumab et ANKET™ seront présentées au congrès virtuel de l’ESMO 2021EU:IPHInnate Pharma
02/09/202108:00GlobeNewswire Inc.Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual CongressEU:IPHInnate Pharma
30/08/202107:00GlobeNewswire Inc.Innate Pharma to Participate in Upcoming Investor ConferencesEU:IPHInnate Pharma
30/08/202107:00GlobeNewswire Inc.Prochains Rendez-Vous Investisseurs d'Innate PharmaEU:IPHInnate Pharma
11/08/202107:00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021EU:IPHInnate Pharma
11/08/202107:00GlobeNewswire Inc.Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Aout 2021EU:IPHInnate Pharma
12/07/202107:00GlobeNewswire Inc.NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021EU:IPHInnate Pharma
12/07/202107:00GlobeNewswire Inc.Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Juillet 2021EU:IPHInnate Pharma
12/07/202107:00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021EU:IPHInnate Pharma
06/07/202107:00GlobeNewswire Inc.Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe PneumoniaEU:IPHInnate Pharma
06/07/202107:00GlobeNewswire Inc.Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe PneumoniaEU:IPHInnate Pharma
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:IPH
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network